Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
11.35
-0.17 (-1.48%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of $314.78 million as of August 26, 2026. Its market cap has increased by 17.60% in one year.
Market Cap
314.78M
Enterprise Value
219.79M
1-Year Change
17.60%
Ranking
Category
Stock Price
$11.35
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from $10.33M to $314.78M, an increase of 2,947.08%. That is a compound annual growth rate of 37.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 314.78M | -9.06% |
| Dec 30, 2025 | 346.13M | 92.86% |
| Dec 30, 2024 | 179.47M | 14.25% |
| Dec 29, 2023 | 157.08M | 11.76% |
| Dec 30, 2022 | 140.55M | 27.27% |
| Dec 30, 2021 | 110.43M | -52.45% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 342.90M |
| SAB Biotherapeutics | 338.47M |
| Anavex Life Sciences | 329.91M |
| Vanda Pharmaceuticals | 328.92M |
| Orchestra BioMed Holdings | 326.07M |
| ProQR Therapeutics | 324.58M |
| InflaRx | 324.21M |
| Cartesian Therapeutics | 320.71M |